You are here

Home

Languages

Viral Hepatitis: Recent Advances in Diagnosis and Treatment

Country: 

Turkey

City: 

Istanbul

Topic: 

Viral Hepatitis

Institution: 

ESCMID Study Group for Viral Hepatitis (ESGVH), Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD) & Turkish Viral Hepatitis Society (VHSD)

Link to Institution: 

https://www.escmid.org/

Price (€): 

413

Language: 

English

Level: 

Postgraduate

Type of Course: 

Advanced

Prerequisites: 

Infectious disease and clinical microbiology specialists and trainees, gastroenterologists and clinicians taking care of patients with viral hepatitis

Date of Start: 

Friday, February 28, 2014

Date of End: 

Saturday, March 1, 2014

Deadline for Application: 

Monday, February 3, 2014

Link for Application: 

https://www.etouches.com/ereg/index.php?eventid=72718

Associated Scholarship: 

NO

Degree delivering: 

Certificate

Keywords: 

Infectious disease, Hepatitis

Contact details: 

Prof Hakan Leblebicioglu Department of Infectious Diseases & Clinical Microbiology Ondokuz Mayis University Medical School Samsun, Turkey Phone +90 533 566 31 38 Fax +90 362 457 60 14

Course Objectives

Increase knowledge about viral hepatitis
Review the epidemiology, prevention and outcome of viral hepatitis
Enhance attendees' understanding of diagnosis of hepatitis
Increase knowledge about the treatment of viral hepatitis and follow-up
Demonstrate all the steps of diagnosis and treatment of chronic viral hepatitis through case discussions
 
Course Programme
Friday, 28 February 2014
 
09:00 Opening session
 
How to deal with guidelines for hepatitis C treatment
Chairs: F. Tabak & C. Hezode
 
09:15 Boceprevir and Telaprevir based triple therapy: guide to guidelines. 
           U. S. Akarca
09:45 Management of patients with non 1 genotypes. A. Mangia
10:15 Management of acute HCV infection. A. Hoepelman
10:45 Coffee break
 
Challenges from a new era in hepatitis C treatment
Chairs: H. Vahaboglu & D. Salmon
 
11:00 Management of side effects of Telaprevir and Boceprevir. Z. Kocak Tufan
11:30 Pharmacogenomics and drugdrug interaction in the treatment of HCV                    chronic hepatitis. G. Di Perri
12:00 Hepatitis C treatment in developing countries: economic perspectives. 
           R. Ozaras
12:30 Lunch
 
Future HCV treatment
Chairs: S. Kaymakoglu & B. Kilani
 
13:30 Anti HCV treatment: what’s coming in the next years. J. E. Arends
14:00 Pre-treatment and on-treatment predictors for decisions of anti HCV                         therapy. W. Irving
 
Round table: case studies (3 groups and rotate)*
14:30 Treatment of chronic hepatitis C in HIV-infected patients in the era of                        direct acting antivirals. D. Salmon
15:00 Coffee break
15:15 Difficult to treat patient 1: the multiexperienced patient, cirrhosis. 
           C.  Hezode
15:45 Difficult to treat patient 2: cryoglobulinaemia, thrombocytopenia, renal                     disease, congenital anaemia. A. Hoepelman
 
* Round table case studies: case presentations with closed questions on 2 or 3 clinical turning points voted by the audience and discussed by the experts.
 
Saturday, 1 March 2014
Hepatitis B
Chairs: C. Agalar & J. E. Arends
 
09:00 Hepatitis B in the immunosuppressed patient. D. Salmon
09:30 Treatment of HBV in HIV infected patients. H. Kumbasar
10:00 Pregnancy and chronic hepatitis. H. Leblebicioglu
10:30 Coffee break
 
Diagnostic workshop (3 groups and rotate)
10:45 Molecular diagnosis of chronic hepatitis. V. Ghisetti
11:15 HBs Ag: new life for an old marker. V. Turhan
11:45 Non-invasive assessment of fibrosis. I. Koksal
12:15 Lunch
 
Hepatitis A and E
Chairs: H. Erdem & V. Ghisetti
 
13:30 Epidemiology of HEV. H. Dalton
14:00 Virology of HEV. W. Irving
14:30 HEV in immunocompromised hosts and pregnant women. B. Kilani
15:00 Coffee break
 
Other hepatitis issues
Chairs: C. Karaca & W. Irving
 
15:15 Indications and waiting list management in liver transplantation. 
            Z. Karasu
15:45 Can we stop chronic hepatitis B treatment? R. Ozaras
16:15 What’s new in delta hepatitis? S. Hosoglu
 

 

16:45 Closing session

 

Attendance Grants

 

ESCMID provides a number of attendance grants for ESCMID “young scientist members”. The grant covers the registration fee, but not accommodation or
travel costs. Please apply online on this website (follow the link on the right) before 17 January 2014. Applicants will be informed about their acceptance by 31 January 2014.

Please note that attendance grant application does not include registration for the course.

 

 

Duration: 

2 days